CVS:NYE-CVS Health Corporation (USD)

EQUITY | Healthcare Plans | New York Stock Exchange

Last Closing

USD 67.14

Change

-0.45 (-0.67)%

Market Cap

USD 78.05B

Volume

6.58M

Analyst Target

USD 78.78
Analyst Rating

N/A

ducovest Verdict

Verdict

About

CVS Health Corp iis an integrated pharmacy health care provider. The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-28 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

N/A

USD 446.97B
ELV Elevance Health Inc

N/A

USD 93.09B
CNC Centene Corp

N/A

USD 28.86B
MOH Molina Healthcare Inc

N/A

USD 17.11B
OSCR Oscar Health Inc

N/A

USD 3.66B
NEUE NeueHealth Inc

N/A

USD 0.06B
CI Cigna Corp

N/A

N/A
HUM Humana Inc

N/A

N/A

ETFs Containing CVS

XFVT:XETRA Xtrackers - FTSE Vietnam .. 4.04 % 0.00 %

N/A

N/A
GLDVD:SW UBS (Irl) ETF plc - S&P D.. 3.79 % 0.00 %

N/A

USD 0.11B
UNCU:LSE First Trust US Equity Inc.. 3.48 % 0.00 %

N/A

USD 0.03B
GEND Spinnaker ETF Series 3.48 % 0.00 %

N/A

N/A
GEDV:LSE SPDR® S&P® Global Divid.. 2.71 % 0.00 %

N/A

USD 0.02B
UVAL:SW SPDR® MSCI USA Value UCI.. 2.63 % 0.00 %

N/A

USD 0.15B
ESN Essential 40 Stock ETF 2.60 % 0.00 %

N/A

USD 0.08B
VMAX REX VolMAXX Long VIX Futu.. 2.16 % 0.00 %

N/A

USD 0.05B
IUVD:LSE iShares Edge MSCI USA Val.. 2.12 % 0.00 %

N/A

USD 0.16B
IUVF:LSE iShares Edge MSCI USA Val.. 2.12 % 0.00 %

N/A

USD 1.91B
IUVL:LSE iShares Edge MSCI USA Val.. 2.12 % 0.00 %

N/A

USD 1.91B
GLDV:SW SPDR® S&P Global Dividen.. 2.01 % 0.00 %

N/A

USD 1.18B
FTA First Trust Large Cap Val.. 1.38 % 0.61 %

N/A

USD 1.13B
WDIV:AU SPDR S&P Global Dividend 1.38 % 0.00 %

N/A

USD 0.28B
RSPE Invesco Exchange-Traded F.. 0.73 % 0.00 %

N/A

USD 0.02B
FAB First Trust Multi Cap Val.. 0.70 % 0.70 %

N/A

USD 0.12B
FEX First Trust Large Cap Cor.. 0.69 % 0.61 %

N/A

USD 1.25B
LUSC:LSE SPDR Barclays 10+ U.S. Co.. 0.43 % 0.00 %

N/A

N/A
LCRP:LSE SPDR Barclays 10+ U.S. Co.. 0.42 % 0.00 %

N/A

USD 0.08B
SUSC:LSE SPDR Barclays 0-3 Year US.. 0.41 % 0.00 %

N/A

N/A
XEWE:XETRA Xtrackers S&P 500 Equal W.. 0.41 % 0.00 %

N/A

USD 4.06B
SYBN:F SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

N/A

USD 0.10B
SYBN:XETRA SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

N/A

N/A
SYBR:F SSgA SPDR ETFs Europe I P.. 0.30 % 0.00 %

N/A

USD 0.23B
SYBR:XETRA SPDR Barclays 3-10 U.S. C.. 0.30 % 0.00 %

N/A

N/A
IUCB:SW SPDR® Bloomberg 1-10 Yea.. 0.30 % 0.00 %

N/A

USD 0.42B
XEWG:LSE Xtrackers S&P 500 Equal W.. 0.27 % 0.00 %

N/A

USD 0.11B
ISPE:LSE iShares S&P 500 Equal Wei.. 0.27 % 0.00 %

N/A

USD 0.73B
EWSX:LSE iShares S&P 500 Equal Wei.. 0.27 % 0.00 %

N/A

N/A
AGGY WisdomTree Yield Enhanced.. 0.00 % 0.12 %

N/A

USD 0.89B
BSCP Invesco BulletShares 2025.. 0.00 % 0.10 %

N/A

N/A
ESGF 0.00 % 0.40 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

N/A

USD 0.08B
FXG First Trust Consumer Stap.. 0.00 % 0.64 %

N/A

USD 0.29B
IBDL 0.00 % 0.10 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

N/A

N/A
ILTB iShares Core 10+ Year USD.. 0.00 % 0.06 %

N/A

USD 0.62B
LQD iShares iBoxx $ Investmen.. 0.00 % 0.15 %

N/A

N/A
PBI:CA Purpose Best Ideas 0.00 % 0.79 %

N/A

CAD 0.01B
SPLB SPDR Barclays Long Term C.. 0.00 % 0.08 %

N/A

USD 1.15B
IG Principal Exchange-Traded.. 0.00 % 0.26 %

N/A

USD 0.10B
IGLB iShares 10+ Year Investme.. 0.00 % 0.10 %

N/A

USD 2.72B
IBDT iShares iBonds Dec 2028 T.. 0.00 % 0.10 %

N/A

USD 2.72B
SSPY Exchange Listed Funds Tru.. 0.00 % 0.00 %

N/A

USD 0.09B
RTH VanEck Retail ETF 0.00 % 0.35 %

N/A

N/A
RWL Invesco S&P 500 Revenue E.. 0.00 % 0.39 %

N/A

N/A
SLQD iShares 0-5 Year Investme.. 0.00 % 0.06 %

N/A

USD 2.24B
SPVU Invesco S&P 500® Enhance.. 0.00 % 0.16 %

N/A

N/A
SPYD SPDR® Portfolio S&P 500 .. 0.00 % 0.08 %

N/A

USD 6.71B
VLUE iShares MSCI USA Value Fa.. 0.00 % 0.15 %

N/A

USD 7.27B
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

N/A

N/A
WDIV SPDR® S&P Global Dividen.. 0.00 % 0.40 %

N/A

USD 0.19B
XHS SPDR® S&P Health Care Se.. 0.00 % 0.35 %

N/A

USD 0.08B
ICAN 0.00 % 0.50 %

N/A

N/A
AIEQ Amplify ETF Trust 0.00 % 0.75 %

N/A

USD 0.11B
FEX:LSE First Trust US Large Cap .. 0.00 % 0.00 %

N/A

USD 0.12B
FEXD:LSE First Trust US Large Cap .. 0.00 % 0.00 %

N/A

USD 0.04B
FEXU:LSE First Trust Global Funds .. 0.00 % 0.00 %

N/A

USD 0.12B
UC84:LSE UBS Barclays US Liquid Co.. 0.00 % 0.00 %

N/A

USD 0.08B
UINC:LSE First Trust US Equity Inc.. 0.00 % 0.00 %

N/A

USD 0.31B
VVAL:LSE 0.00 % 0.00 %

N/A

N/A
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
ZPRU:XETRA SPDR MSCI USA Value UCITS.. 0.00 % 0.00 %

N/A

N/A
GBLO 0.00 % 0.00 %

N/A

N/A
NVQ 0.00 % 0.00 %

N/A

N/A
SHUS Exchange Listed Funds Tru.. 0.00 % 0.00 %

N/A

USD 0.03B

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 49.57% 100% F 99% N/A
Dividend Return 1.48% 100% F 66% D+
Total Return 51.05% 100% F 99% N/A
Trailing 12 Months  
Capital Gain -15.82% 56% F 19% F
Dividend Return 3.34% 100% F 57% F
Total Return -12.49% 56% F 19% F
Trailing 5 Years  
Capital Gain 14.57% 50% F 35% F
Dividend Return 19.53% 100% F 48% F
Total Return 34.10% 50% F 32% F
Average Annual (5 Year Horizon)  
Capital Gain -0.70% 33% F 28% F
Dividend Return 1.84% 56% F 31% F
Total Return 2.54% 100% F 57% F
Risk Return Profile  
Volatility (Standard Deviation) 29.51% 22% F 34% F
Risk Adjusted Return 6.22% 56% F 25% F
Market Capitalization 78.05B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Healthcare Plans) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 15.90 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector